Bavarian Nordic Awarded Another Contract to Supply Smallpox Vaccines for EU Strategic Reserve
Bavarian Nordic A/S (OMX: BAVA) announced today, that it has been awarded another contract valued at more than EUR 11 million to supply its MVA-BN® smallpox vaccine to rescEU, a strategic reserve within the European Union (EU). This order follows an Mehr




